Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 194
2002 175
2003 183
2004 179
2005 284
2006 296
2007 279
2008 293
2009 288
2010 307
2011 366
2012 314
2013 397
2014 431
2015 554
2016 473
2017 446
2018 613
2019 813
2020 1186
2021 1218
2022 1139
2023 1805
2024 646

Text availability

Article attribute

Article type

Publication date

Search Results

11,200 results

Results by year

Filters applied: . Clear all
Page 1
Peptide nanovaccine in melanoma immunotherapy.
Dehghankhold M, Sadat Abolmaali S, Nezafat N, Mohammad Tamaddon A. Dehghankhold M, et al. Int Immunopharmacol. 2024 Mar 10;129:111543. doi: 10.1016/j.intimp.2024.111543. Epub 2024 Jan 31. Int Immunopharmacol. 2024. PMID: 38301413 Review.
The role of ANXA1 in the tumor microenvironment.
Li L, Wang B, Zhao S, Xiong Q, Cheng A. Li L, et al. Int Immunopharmacol. 2024 Mar 12;131:111854. doi: 10.1016/j.intimp.2024.111854. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38479155 Review.
Defensins: A novel weapon against Mycobacterium tuberculosis?
Gao X, Feng J, Wei L, Dong P, Chen J, Zhang L, Yang Y, Xu L, Wang H, Luo J, Qin M. Gao X, et al. Int Immunopharmacol. 2024 Jan 25;127:111383. doi: 10.1016/j.intimp.2023.111383. Epub 2023 Dec 20. Int Immunopharmacol. 2024. PMID: 38118315 Review.
11,200 results
You have reached the last available page of results. Please see the User Guide for more information.